&nbsp;

ColorectalAcknowledgements.pdf

Dec 1969

Drug

Enhertu trastuzumab deruxtecan

Other Name(s): Enhertu™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Regimen

ENHE

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab Deruxtecan - HER2-low Unresectable Locally Advanced or Metastatic Breast Cancer

Enhertu trastuzumab deruxtecan

Drugs Used:

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Drug

crisantaspase recombinant

Other Name(s): Rylaze™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Dec 1969

Document

CoP-Fall2023.pdf

Dec 1969

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2023

Status: Current
ID: PET 2023-1

Nov 2023

Document

CART-cellTherapyForAdultWithRelapsedRefractoryB-cellALL.pdf

Dec 1969

Document

CART-cellTherapyforPediatricRelapsedRefractoryB-cellALL.pdf

Dec 1969

Regimen

CARFDEXASELI

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

, Collapse Show fewer tags

Drugs Used:

carfilzomib (Unfunded),

dexamethasone,

selinexor (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2024

Regimen

EPCO; EPCO(RAMP)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Funding:

New Drug Funding Program

Epcoritamab (Outpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma

High Cost Therapy Funding Program

Epcoritamab (Inpatient) - Relapsed or Refractory Diffuse Large B-Cell Lymphoma

, Collapse Show fewer tags

Drugs Used:

epcoritamab

... Show more tags

Quick Link(s):

Regimen Monograph

Nov 2024

Document